Featured Products
Welcome
At Amneal we are committed to forming deep relationships with our customers and business partners as well as creating strong value throughout the supply chain. That’s why we've created this website. Get to know Amneal, as a company, partner, supplier, employer or customer. At amneal.com we provide valuable information about our operations, leaders, products, business principles and more… as well as details on how to get in touch with us.
Welcome to Amneal Pharmaceuticals—generic’s new generation. We encourage you to learn more about our remarkable company. Explore our site.
News and Press
AMNEAL EXPANDS GENERIC PORTFOLIO WITH LAUNCH OF ALPRAZOLAMER AND BENAZEPRIL HCI TABLETS
Amneal Pharmaceuticals is pleased to announce the availability of its Alprazolam Extended Release Tablets in strengths of 0.5 mg, 1 mg, 2 mg and 3 mg.
More »
Amneal Pharmaceuticals is pleased to announce the availability of its Alprazolam Extended Release Tablets in strengths of 0.5 mg, 1 mg, 2 mg and 3 mg.
More »
AMNEAL RECEIVES RARE FDA APPROVAL FOR EXTENDED PHENYTOIN SODIUM CAPSULES, USP
Amneal Pharmaceuticals is pleased to announce that it has received confirmation from the US FDA that its Extended Phenytoin Sodium Capsules, USP 100 mg are bioequivalent to Mylan's Extended Phenytoin Sodium Capsules.
More »
Amneal Pharmaceuticals is pleased to announce that it has received confirmation from the US FDA that its Extended Phenytoin Sodium Capsules, USP 100 mg are bioequivalent to Mylan's Extended Phenytoin Sodium Capsules.
More »
AMNEAL RECEIVES FDA APPROVAL FOR ITS SECOND LIQUID RX PRODUCT, PREDNISOLONE SODIUM PHOSPHATE, USP
Amneal Pharmaceuticals is pleased to announce that it has received US FDA approval to manufacture Prednisolone Sodium Phosphate Oral Solution in 15 mg/5 mL strength, effective March 10, 2009.
More »
Amneal Pharmaceuticals is pleased to announce that it has received US FDA approval to manufacture Prednisolone Sodium Phosphate Oral Solution in 15 mg/5 mL strength, effective March 10, 2009.
More »